Actively Recruiting
Observational Study of Iris Tumors
Led by Oregon Health and Science University · Updated on 2025-09-09
100
Participants Needed
1
Research Sites
493 weeks
Total Duration
On this page
Sponsors
O
Oregon Health and Science University
Lead Sponsor
N
National Eye Institute (NEI)
Collaborating Sponsor
AI-Summary
What this Trial Is About
This is an observational study using OCT angiography to assist with tumor characterization in melanotic and amelanotic iris lesions. OCT angiography data from healthy eyes will be compared to eyes with various types of iris tumors.
CONDITIONS
Official Title
Observational Study of Iris Tumors
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Eyes with diagnosis of melanotic or amelanotic iris tumors
- Eyes without iris defects or lesions
You will not qualify if you...
- Inability to give informed consent
- Inability to maintain stable fixation for OCT imaging
- Inability to commit to required study visits
- Eyes with retinal diseases, glaucoma, or conditions affecting iris circulation
- Mature cataracts limiting vision to worse than 20/40
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Oregon Health & Science University
Portland, Oregon, United States, 97239
Actively Recruiting
Research Team
D
Denzil Romfh, OD
CONTACT
H
Humberto Martinez, COT
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here